| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |